Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

GS Future Health Care Equity ETF (GDOC)

GS Future Health Care Equity ETF (GDOC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Goldman Sachs
  • Assets Under Management 22,568,200
  • Shares Outstanding, K 620
  • 60-Month Beta 0.83
  • Price/Earnings ttm 35.52
  • Annual Dividend & Yield 0.11 (0.31%)
  • Most Recent Dividend 0.113 on 12/23/25
  • Management Fee 0.75%

Price Performance

See More
Period Period Low Period High Performance
1-Month
35.24 +3.28%
on 01/05/26
36.74 -0.93%
on 01/07/26
+1.07 (+3.04%)
since 12/09/25
3-Month
32.82 +10.91%
on 10/10/25
37.33 -2.49%
on 11/26/25
+3.01 (+9.02%)
since 10/09/25
52-Week
28.34 +28.44%
on 04/09/25
37.33 -2.49%
on 11/26/25
+3.34 (+10.09%)
since 01/08/25

Most Recent Stories

More News
Goldman Sachs Thinks Mid-Cap Biotech MoonLake Could Soar Over 80%: Is Retail Watching Closely?

Oppenheimer has included MoonLake among its top biotech picks for 2025, alongside Capricor, Gilead, Kymera, Praxis, and Prothena.

GURU : 62.75 (+0.49%)
GDOC : 36.40 (+0.35%)
SBIO : 51.37 (+1.58%)
MLTX : 18.49 (+28.94%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The Goldman Sachs Future Health Care Equity ETF seeks long-term growth of capital.

See More

Top 10 Holdings

Name % Holdings

See More

Key Turning Points

3rd Resistance Point 36.40
2nd Resistance Point 36.40
1st Resistance Point 36.40
Last Price 36.40
1st Support Level 36.40
2nd Support Level 36.40
3rd Support Level 36.40

See More

52-Week High 37.33
Last Price 36.40
Fibonacci 61.8% 33.90
Fibonacci 50% 32.83
Fibonacci 38.2% 31.77
52-Week Low 28.34

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar